Andreas Strüngmann: Difference between revisions
Content deleted Content added
m Persondata |
No edit summary |
||
| Line 1: | Line 1: | ||
{{No references|date=May 2013}} |
|||
'''Andreas Strüngmann''' (born 1950) was born in Germany and founded [[generic drug]] maker [[Hexal|Hexal AG]] ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer. In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. [[Eon Labs]] to [[Novartis]] for $7.5 billion, making [[Sandoz]] the largest generic-drug company in the world. |
'''Andreas Strüngmann''' (born 1950) was born in Germany and founded [[generic drug]] maker [[Hexal|Hexal AG]] ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer. In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. [[Eon Labs]] to [[Novartis]] for $7.5 billion, making [[Sandoz]] the largest generic-drug company in the world. |
||
Revision as of 08:13, 16 May 2013
 |
Andreas Strüngmann (born 1950) was born in Germany and founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer. In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion, making Sandoz the largest generic-drug company in the world.
He currently has residences in Tegernsee, Germany, Europe and Russia and is married with two children. At age 56, he accepted an executive position at Sandoz, a generics division of Novartis.
See also
References
External links
| International | |
|---|---|
| National | |
 | This German business-related biographical article is a stub. You can help Wikipedia by expanding it. |